Northern Trust’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $218K | Sell |
31,651
-68,232
| -68% | -$471K | ﹤0.01% | 3911 |
|
|
2025
Q1 | $530K | Sell |
99,883
-3,381
| -3% | -$18K | ﹤0.01% | 3554 |
|
|
2024
Q4 | $1.22M | Buy |
103,264
+11,400
| +12% | +$135K | ﹤0.01% | 3304 |
|
|
2024
Q3 | $1.9M | Buy |
91,864
+66,089
| +256% | +$1.36M | ﹤0.01% | 3040 |
|
|
2024
Q2 | $1.17M | Buy |
25,775
+5,764
| +29% | +$261K | ﹤0.01% | 3174 |
|
|
2024
Q1 | $785K | Buy |
+20,011
| New | +$785K | ﹤0.01% | 3406 |
|
|
2023
Q1 | – | Sell |
-6,911
| Closed | -$22.9K | – | 4587 |
|
|
2022
Q4 | $22.9K | Sell |
6,911
-183
| -3% | -$607 | ﹤0.01% | 4464 |
|
|
2022
Q3 | $35K | Hold |
7,094
| – | – | ﹤0.01% | 4417 |
|
|
2022
Q2 | $53K | Sell |
7,094
-13
| -0.2% | -$97 | ﹤0.01% | 4386 |
|
|
2022
Q1 | $113K | Sell |
7,107
-13
| -0.2% | -$207 | ﹤0.01% | 4308 |
|
|
2021
Q4 | $132K | Sell |
7,120
-136
| -2% | -$2.52K | ﹤0.01% | 4335 |
|
|
2021
Q3 | $222K | Buy |
7,256
+145
| +2% | +$4.44K | ﹤0.01% | 4124 |
|
|
2021
Q2 | $390K | Sell |
7,111
-19,471
| -73% | -$1.07M | ﹤0.01% | 3822 |
|
|
2021
Q1 | $1.57M | Sell |
26,582
-1,013
| -4% | -$59.9K | ﹤0.01% | 3376 |
|
|
2020
Q4 | $1.04M | Sell |
27,595
-245
| -0.9% | -$9.19K | ﹤0.01% | 3502 |
|
|
2020
Q3 | $1.5M | Buy |
27,840
+1,833
| +7% | +$99K | ﹤0.01% | 3199 |
|
|
2020
Q2 | $6.55M | Sell |
26,007
-399
| -2% | -$100K | ﹤0.01% | 2356 |
|
|
2020
Q1 | $4.15M | Buy |
26,406
+3,214
| +14% | +$505K | ﹤0.01% | 2411 |
|
|
2019
Q4 | $3.8M | Buy |
23,192
+150
| +0.7% | +$24.6K | ﹤0.01% | 2754 |
|
|
2019
Q3 | $3.37M | Buy |
23,042
+2,706
| +13% | +$395K | ﹤0.01% | 2786 |
|
|
2019
Q2 | $4.23M | Sell |
20,336
-667
| -3% | -$139K | ﹤0.01% | 2650 |
|
|
2019
Q1 | $4.38M | Buy |
21,003
+1,437
| +7% | +$300K | ﹤0.01% | 2635 |
|
|
2018
Q4 | $3.43M | Sell |
19,566
-284
| -1% | -$49.8K | ﹤0.01% | 2736 |
|
|
2018
Q3 | $4.5M | Buy |
19,850
+772
| +4% | +$175K | ﹤0.01% | 2746 |
|
|
2018
Q2 | $2.89M | Buy |
19,078
+1,346
| +8% | +$204K | ﹤0.01% | 3001 |
|
|
2018
Q1 | $3.25M | Buy |
17,732
+260
| +1% | +$47.6K | ﹤0.01% | 2838 |
|
|
2017
Q4 | $3.72M | Buy |
17,472
+746
| +4% | +$159K | ﹤0.01% | 2784 |
|
|
2017
Q3 | $3.59M | Buy |
16,726
+648
| +4% | +$139K | ﹤0.01% | 2838 |
|
|
2017
Q2 | $3.04M | Buy |
16,078
+14,320
| +815% | +$2.71M | ﹤0.01% | 2912 |
|
|
2017
Q1 | $435K | Buy |
1,758
+247
| +16% | +$61.1K | ﹤0.01% | 3574 |
|
|
2016
Q4 | $383K | Sell |
1,511
-4
| -0.3% | -$1.01K | ﹤0.01% | 3593 |
|
|
2016
Q3 | $309K | Buy |
1,515
+441
| +41% | +$89.9K | ﹤0.01% | 3621 |
|
|
2016
Q2 | $96K | Buy |
1,074
+224
| +26% | +$20K | ﹤0.01% | 3898 |
|
|
2016
Q1 | $46K | Hold |
850
| – | – | ﹤0.01% | 4035 |
|
|
2015
Q4 | $42K | Hold |
850
| – | – | ﹤0.01% | 4075 |
|
|
2015
Q3 | $40K | Buy |
850
+483
| +132% | +$22.7K | ﹤0.01% | 4113 |
|
|
2015
Q2 | $34K | Buy |
+367
| New | +$34K | ﹤0.01% | 4108 |
|